Table 4

Multivariate analysis

End pointNFactorOR95% CIP
Relapse 110 Donor rs10925027 TT in NLRP3 6.3 3.1-12.5 1 × 10−7 
  Patient rs11665831 CC in CARD8 2.6 1.3-5.3 .007 
NRM 114 Donor rs1043684 GG in NLRP2 4.4 1.8-10.3 6 × 10−4 
  Patient rs5862 AA in NLRP1 2.8 1.3-5.7 .005 
OS 114 Donor rs1043684 GG in NLRP2 3.1 1.7-5.6 .0001 
  Advanced phase 2.8 1.4-5.4 .002 
  Older age 2.4 1.3-4.5 .006 
  Patient rs5862 AA in NLRP1 2.0 1.2-3.4 .009 
End pointNFactorOR95% CIP
Relapse 110 Donor rs10925027 TT in NLRP3 6.3 3.1-12.5 1 × 10−7 
  Patient rs11665831 CC in CARD8 2.6 1.3-5.3 .007 
NRM 114 Donor rs1043684 GG in NLRP2 4.4 1.8-10.3 6 × 10−4 
  Patient rs5862 AA in NLRP1 2.8 1.3-5.7 .005 
OS 114 Donor rs1043684 GG in NLRP2 3.1 1.7-5.6 .0001 
  Advanced phase 2.8 1.4-5.4 .002 
  Older age 2.4 1.3-4.5 .006 
  Patient rs5862 AA in NLRP1 2.0 1.2-3.4 .009 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal